Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ABT vs MRNA✓SelectedUSD · MRNAABT vs MRNA performance historyLatest closeAs of-0.84%11/20
Stock and ETF performance explorer

ABT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-14.9%
MRNA return
+697.5%
Excess return
-712.4%
Maximum drawdown
-35.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.8%-2.2%+1.3%-0.8%
7D-5.1%-12.7%+7.6%-5.0%
30D+2.5%-20.7%+23.1%+2.7%
3M-9.2%+46.3%-55.5%-9.5%
6M+18.1%+305.2%-287.1%+15.9%
YTD-15.7%+561.2%-577.0%-19.2%
1Y-14.9%+772.1%-786.9%-21.1%
All-14.9%+697.5%-712.4%-21.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling